{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:31:18Z","timestamp":1761863478345},"reference-count":10,"publisher":"Europa Digital & Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.4244\/eijy14m09_08","type":"journal-article","created":{"date-parts":[[2015,8,9]],"date-time":"2015-08-09T10:04:00Z","timestamp":1439114640000},"page":"e1-e2","source":"Crossref","is-referenced-by-count":20,"title":["Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients"],"prefix":"10.4244","volume":"11","author":[{"given":"Yuki","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-201589112929-0","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.","volume":"123","author":"Kolandaivelu K.","year":"2011","journal-title":"Circulation."},{"key":"key-201589112929-1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.","volume":"5","author":"Guagliumi G.","year":"2012","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201589112929-2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/eurheartj\/ehm114","article-title":"Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.","volume":"28","author":"Siqueira DA.","year":"2007","journal-title":"Eur Heart J."},{"key":"key-201589112929-3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCINTERVENTIONS.111.963710","article-title":"Bioresorbable polymeric vascular scaffolds: a cautionary tale.","volume":"4","author":"Ormiston JA.","year":"2011","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201589112929-4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10554-014-0374-3","article-title":"Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions.","volume":"30","author":"Bourantas CV.","year":"2014","journal-title":"Int J Cardiovasc Imaging."},{"key":"key-201589112929-5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4244\/EIJV7I3A64","article-title":"Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application.","volume":"7","author":"Farooq V.","year":"2011","journal-title":"EuroIntervention."},{"key":"key-201589112929-6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcin.2012.12.131","article-title":"Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.","volume":"6","author":"Farooq V.","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201589112929-7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4244\/EIJV10I4A78","article-title":"Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial.","volume":"10","author":"Ishibashi Y.","year":"2014","journal-title":"EuroIntervention."},{"key":"key-201589112929-8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes.","volume":"385","author":"Serruys PW.","year":"2015","journal-title":"Lancet."},{"key":"key-201589112929-9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","article-title":"Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design.","volume":"167","author":"Woudstra P.","year":"2014","journal-title":"Am Heart J."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:18:12Z","timestamp":1498238292000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/86th_issue\/73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["20140908-04"],"URL":"https:\/\/doi.org\/10.4244\/eijy14m09_08","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}